Hudson Valley Investment Advisors Inc. ADV maintained its position in shares of Colgate-Palmolive Company (NYSE:CL) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,263 shares of the company’s stock at the end of the second quarter. Hudson Valley Investment Advisors Inc. ADV’s holdings in Colgate-Palmolive were worth $390,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. CWM LLC boosted its position in shares of Colgate-Palmolive by 2.8% in the second quarter. CWM LLC now owns 3,266 shares of the company’s stock valued at $242,000 after buying an additional 88 shares during the last quarter. TNB Financial boosted its position in shares of Colgate-Palmolive by 27.6% in the second quarter. TNB Financial now owns 16,159 shares of the company’s stock valued at $1,198,000 after buying an additional 3,499 shares during the last quarter. Palo Capital Inc. boosted its position in shares of Colgate-Palmolive by 1.6% in the second quarter. Palo Capital Inc. now owns 20,513 shares of the company’s stock valued at $1,521,000 after buying an additional 320 shares during the last quarter. Winslow Evans & Crocker Inc. boosted its position in shares of Colgate-Palmolive by 3.3% in the second quarter. Winslow Evans & Crocker Inc. now owns 32,645 shares of the company’s stock valued at $2,419,000 after buying an additional 1,037 shares during the last quarter. Finally, OLD National Bancorp IN boosted its position in shares of Colgate-Palmolive by 8.3% in the second quarter. OLD National Bancorp IN now owns 10,280 shares of the company’s stock valued at $762,000 after buying an additional 791 shares during the last quarter. Institutional investors own 73.50% of the company’s stock.
Colgate-Palmolive Company (NYSE:CL) opened at 73.27 on Friday. The company’s 50-day moving average is $74.80 and its 200 day moving average is $72.20. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The company has a market cap of $64.72 billion, a price-to-earnings ratio of 26.44 and a beta of 0.80. Colgate-Palmolive also was the recipient of some unusual options trading on Thursday. Stock traders bought 11,545 put options on the stock. This represents an increase of approximately 508% compared to the average volume of 1,900 put options.
Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. The firm had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,725.55% and a net margin of 16.31%. The business’s quarterly revenue was down .5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.70 EPS. Equities analysts forecast that Colgate-Palmolive Company will post $2.93 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.18%. The ex-dividend date is Friday, July 14th. Colgate-Palmolive’s payout ratio is 57.76%.
COPYRIGHT VIOLATION WARNING: This article was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://stocknewstimes.com/2017/07/22/colgate-palmolive-company-cl-stake-maintained-by-hudson-valley-investment-advisors-inc-adv.html.
Several research analysts have commented on the stock. BidaskClub cut shares of Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Jefferies Group LLC raised their target price on shares of Colgate-Palmolive from $76.00 to $77.00 and gave the stock a “hold” rating in a report on Thursday, July 6th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a report on Tuesday, July 4th. Royal Bank Of Canada reiterated a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a report on Friday, June 30th. Finally, Bank of America Corporation raised their target price on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, May 31st. One investment analyst has rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and a consensus price target of $75.69.
In other Colgate-Palmolive news, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $72.41, for a total value of $277,547.53. Following the sale, the insider now owns 53,022 shares in the company, valued at approximately $3,839,323.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP John J. Huston sold 14,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 10th. The shares were sold at an average price of $71.53, for a total value of $1,001,420.00. Following the completion of the sale, the senior vice president now owns 102,838 shares in the company, valued at approximately $7,356,002.14. The disclosure for this sale can be found here. Insiders sold a total of 29,666 shares of company stock worth $2,144,371 in the last 90 days. Company insiders own 1.02% of the company’s stock.
About Colgate-Palmolive
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.
